Microbiology Flashcards
(281 cards)
Describe the Phylogenetic Tree of Life
Bacteria:
Thermotoga,
Green nonsulfur bacteria,
Bacteroides,
Cyanobacteria,
Gram positives
Purple bacteria.
Archaea:
Thermoproteus,
Pyrodictium,
Thermococcales,
Methanococcales,
Methanobacteriales,
Methanomicrobiales
Extreme Halophiles.
Eucarya:
Microsporidia,
Flagellates,
Animalia
Fungi,
Ciliates,
Plantae.
What organisms does the human microbiome involve?
Stomach 10^2: Lactobacillus, Candida, Streptococcus, Heliobacter pylori, Peptostreptococcus
Duodenum 10^2: Streptococcus, Lactobacillus
Jejunm 10^2: Streptococcus, Lactobacillus
Proximal ileum 10^2: Streptococcus, Lactobacillus
Distal ileum 10^8: Clostridium, Streptococcus, Bacteroides, Actinomycinae, Corneybacteria
Colon 10^12: Bacteroides, Clostridium, Bifidobacterium, Enterobateriacae
What are factors affecting development of the microbiome?
Maternal factors: gut microbiome, vaginal infection, periodontitis
Birth: vaginal (lactobacillus) vs caesarean (staphylococcus, propionibacterium) delivery
Postnatal factors: antibiotics (microbiota depletion), breast-feeding (bifidobacterium, lactobacillus), host-genetics (christensenellacae - associated with lower BMI), environment (familial transmission, environmental exposure)
Infant (<1 year): milk consumption (bifidobacterium, lactobacillus, veillonella), solid food introduction (bacteroides, clostridiales)
Toddler (1-3 years): full adult diet (adult-like microbiota)
How does breast milk affect the microbiota?
Rich in human milk oligosaccharides (HMO), but babies cannot digest them.
Bifidobacterium longum infantis contains all the enzymes required,
Releases short chain fatty acids (SFCA), which then provide energy for intestinal cells,
Promotes production of anti-inflammatory molecules.
B. infantis also produces sialic acid required for brain development.
What affects the adult microbiome?
Share microbiota with your household, environment, pets, food;
Altered by antibiotics;
Reduces in variety as we age.
What is the function of the microbiome?
• Energy biogenesis
• Protection from pathogenic bacteria
• Immune system education
• Vitamin production
• Host cell proliferation
• Brain function
• Bile salt metabolism
• Drug metabolism and activity
What is energy biogenesis?
Resistant starch broken down by the microbiome to short chain fatty-acid (SCFAs) by fermentation,
These include butyrate, pyruvate, acetate;
Butyrate main energy source for enterocyte (intestinal lining cell).
SFCAs have anti-inflammatory and anti-tumour properties,
SFCAs stimulate production of protein YY (PYY), which induces satiety.
Resistant starch as a pre-biotic also promotes weight loss.
How does the microbiota provide protection from pathogenic bacteria?
Niche competition and nutrient depletion from invading bacteria:
Complex inter-related niches,
Mucin layer of the gut mucosa heavily colonized and competes for cell surface receptors,
Promotes development of health epithelium.
SFCAs inhibit virulence gene expression and lower pH to below optimal growth conditions.
Microbiota produce bacteriocins. Directly kill Salmonella, Listeria, Clostridium.
What is the gut-brain axis?
Neural connections involving central, autonomic and enteral nervous system;
Strong links between GI and brain function - depression, anxiety and GI symptoms; irritable bowel syndrome;
Potential involvement in CNS disorders - Parkinson’s and Alzheimer disease, Multiple sclerosis.
Adrenergic nerve causes noradrenaline release in gut mucosa, can alter microbiota composition;
This effects:
Afferent nerve cell of vagus nerve/spinal cord carries signals back to brain,
Cytokines released from transmembrane dendritic cells (DC),
5-HT release from entero endocrine cells,
Bacterial molecules (fatty acids, GABA, 5-HT precursors);
Circulating molecules detected by area posterma, or afferent goes to brain directly;
This brings about an effect in the Limbic system, responsible for emotions and stress.
Beneficial molecules produced by bacteria: Oxytocin increase, GABA (gamma amino butyric acid) increase, BDNF (brain-derived neurotrophic factor) decrease, 4-EPS (4-ethylphenylsulfate) decrease, SCFA increase
What are some examples of gut microorganisms and their effect on the gut-brain axis?
Lactobacillus reuteri: increases Oxytocin, affects Vagus nerve - Regulates neuronal plasticity, increases social behaviour, increases oxytocin levels, increases oxytocin neurones.
Lactobacillus rhamnosus: increases GABA, affects Vagus nerve - decreases stress responsiveness, decreases anxiety and depressive-like behaviour, increases Vagal mesenteric nerve firing;
GABA-Aa2 and GABA-B1b altered mRNA expression in mesolimblic brain structures.
Bifidobacterium longum NCC3001: increases BDNF, affects Vagus nerve - decreases Anxiety-like and depressive behaviour, decreases Excitability ENS neurons
Bacteroides fragilis: decreases 4-EPS circulating - decreases anxiety-like behaviour, decreases repetitive behaviour, increases communication
SCFA-producing bacteria: increases SCFA circulating - decreases stress response, decreases anxiety and depressive like behaviour;
Resting microglia undergoes neuroinflammation to activate
GABA = gamma amino butyric acid
BDNF = brain-derived neurotrophic factor
4-EPS = 4-ethylphenylsulfate
What are Microbiome produced secondary bile acids?
Primary bile acids produced in liver from cholesterol metabolism, involved in emulsification of fat. Intestinal bacteria (microbiome) biotransform some of the primary bile acids into secondary bile acids.
Activate cell surface and nuclear hormone receptors on Hepatocytes, Intestinal cells, Inflammatory cells.
Important in maintaining normal health: Reduce gut inflammation, Regulate synthesis of bile acids, Activate vitamin D receptor.
Stimulates glucagon like peptide-1: increases insulin secretion, reduces glucagon secretion.
What is the microbiome role in disease?
Microbiome has important physiological and homeostatic roles. A number of studies has identified associations between altered microbiome and disease:
Obesity and type 2 diabetes mellitus,
Inflammatory bowel disease,
Colon cancer,
Asthma,
Neurodegenerative disease.
What is the effect of the microbiome on obesity?
Many reasons to consider the microbiome to be important in obesity:
Bacteria involved in energy production,
Stimulate production of mediators that alter insulin and glucagon production,
Involved in satiety,
Regulate intestinal integrity and inflammation.
In experiment, lean subjects had more bacteroidetes and weight loss was associated with increased bacteroidetes.
Clear associations, plausible mechanisms and possible treatments. Probiotics shown to lower cholesterol and fasting blood glucose in patients with type 2 diabetes mellitus.
In mouse experiments, mice with microbiome lay down more fat with less food consumption than germ-free mice. Also, germ-free mice inoculated with microbiota from obese or lean human twins take on the microbiota characteristics of the donor.
What is inflammatory bowel disease?
Two major conditions:
Ulcerative colitis - affects the colon,
Crohn’s disease - can affect any part of gut from mouth to anus.
Both have chronic inflammation, relapsing and remitting, usually treated by suppressing the immune system.
Incidence and prevalence appear to be increasing - increasing as countries have increasing wealth, more common in north than south of the globe.
Most common presentation is with abdominal pain, diarrhoea and weight loss.
Perturbations of intestinal microbiome implicated:
Decreased microbial diversity,
Some bacteria are decreased (Firmicutes, some Clostridium species),
Some bacteria are increased (Enterobacteriaceae - including E.Coli, Facultative anaerobes).
Alterations in gut microbiome composition during disease include reduced microbial diversity and expansion of facultative anaerobes due to increased nitrosative and oxidative stress in the gut.
What is treatment of inflammatory bowel disease?
Anti-inflammatory treatment:
Aminosalicylic acid, glucocorticoids;
Anti-tumour necrosis factor.
Enteral nutrition-used in Crohn disease, which will alter microbiome.
Surgery often required.
No routine place for microbiome based therapy such as probiotics.
What are risk factors for colon cancer?
Increased risk with obesity, insulin resistance, increased red meat intake;
Epidemiological studies show increased fibre intake probably protective,
Physical activity is protective.
Possible common mechanisms involving the microbiome or just associations - Microbiome differs in patients in colon cancer:
Seven bacterial species consistently elevated (e.g. Bacteroides fragilis-produces a tumorigenic toxin),
Large number of bacteria are reduced,
Also changes in the virome.
How is the microbiome related to colon cancer?
Microbiome differs in patients in colon cancer:
Seven bacterial species consistently elevated (e.g. Bacteroides fragilis-produces a tumorigenic toxin),
Large number of bacteria are reduced,
Also changes in the virome.
Microbiome protective effects: Production of SFCAs, Phytochemicals metabolized in colon. Both have anti-inflammatory effects.
Microbiome harmful effects:
Fermentation of diet derived protein to phenols, indoles,
N-nitroso compounds also produced which can be carcinogenic,
Ammonia also produced which can damage colonic epithelia,
Secondary bile acids can promote DNA damage.
Metabolic output of the microbiome likely to alter risk of development and progression of colorectal cancer.
What is does microbiome treatment involve?
Microbiome is a complex ecosystem with multiple bacteria, archae, viruses and fungi; Many genes and metabolic pathways; Therapy is at an early stage.
Role of probiotics:
Helicobacter pylori in peptic ulceration;
Clostridioides difficile infection.
Probiotics most commonly contain Lactobacillus and Bifidobacterium - derived from cultured milk sources;
Evidence of health benefit is limited:
Potential benefits in type 2 diabetes control;
Infectious diarrhoea - no evidence of affect on duration of diarrhoea or hospitalisation;
Ulcerative colitis - no evidence that helps treat acute disease or maintain remission;
Neonatal necrotizing enterocolitis (ischaemic damage to intestinal mucosa that occurs in preterm infants) - studies may show a benefit but flawed design, not routinely used.
What is helicobacter pylori infection?
Helicobacter pylori can be found in the gastric mucosa. Has the enzyme urease which breaks down urea to produce ammonia which neutralizes gastric acidity. Attaches to the gastric mucosa.
Most common chronic bacterial infection in humans, Present in early humans, Estimates 50% of human population infected, Most commonly acquired in childhood.
Pathophysiology:
Disrupts gastric mucus layer leading to exposure of mucosa to acidic environment,
Promotes inflammatory immune response,
Causes chronic gastritis (may be asymptomatic, but can lead to peptic ulceration),
Increases the risk of stomach cancer.
What is peptic ulcer disease?
Often asymptomatic but may cause bleeding leading to anaemia.
Upper abdominal pain, indigestion, heartburn. Occasionally they perforate causing severe pain.
What is investigation and treatment for H. Pylori?
Investigation:
Urea breath test - Give carbon-14 labeled urea and detect labelled CO2 in breath,
Stool antigen test,
Endoscopy and biopsy.
Treatment:
Proton pump inhibitor (e.g. lansoprazole) - suppress acid secretion,
Antibiotics 7 day course - Amoxicillin and clarithromycin or metronidazole.
What is Clostridioides difficile Infection?
How do you treat and prevent it?
Causes antibiotic associated colitis. During antibiotic usage C. Diff is resistant and has selective advantage.
Prevention: Antibiotic stewardship - some antibiotics are more likely to cause C. Diff infection (e.g. ciprofloxacin, clindamycin, cephalosporins); Infection control measures.
Treatment:
Most cases respond to antibiotic treatment (e.g. vancomycin or metronidazole),
But some are resistant and/or recurrent;
Faecal microbiota transplantation (FMT) - instillation of processed stool from a healthy donor into the intestinal tract - reserved for patients with recurrent disease, delivering a “healthy microbiome”, can be delivered by oral capsule/nasojejunal or nasoduodenal tube/Enema/Colonoscopy, 91% effective after 8 weeks with repeat FMT.
What are Infections, Pathogens, Pathogenicity, Colonizations, Carriers, Virulence factors, and Virulence?
Infections: present at a body site, causing disease, can be localised or systemic;
Pathogens: can cause disease, primary pathogen can cause disease in healthy individuals, opportunistic pathogen causes disease in certain hosts (e.g. immunocompsomised);
Colonizations: present at a body site, doing no harm, no symptoms, Patients can be ‘carriers’;
Carriers: have colonisation;
Virulence factors: Genes, molecules, or structures that contribute to virulence (may be cell membrane associated, Cytosolic, Excreted);
Virulence: The relative ability of a pathogenic organism to cause disease;
Pathogenicity: the ability to inflict disease on the host.
What is the ‘Iceberg concept of infection’?
Biological response gradient - can’t see everyone infected (no/mild symptoms), only those with severe/moderate symptoms are identified.